Sakuma, Kenji
364  results:
Search for persons X
?
2

Comparison of brexpiprazole, aripiprazole, and placebo for ..:

Kishi, Taro ; Sakuma, Kenji ; Saito, Takeo...
Neuropsychopharmacology Reports.  44 (2024)  1 - p. 165-175 , 2024
 
?
3

External Validation of a Machine Learning Model for Schizop..:

He, Yupeng ; Sakuma, Kenji ; Kishi, Taro...
Journal of Clinical Medicine.  13 (2024)  10 - p. 2970 , 2024
 
?
4

Antidepressants available in Japan for older people with ma..:

Kishi, Taro ; Sakuma, Kenji ; Hatano, Masakazu...
Neuropsychopharmacology Reports.  44 (2024)  1 - p. 267-271 , 2024
 
?
6

Acceptability of antipsychotic transdermal patch for acute ..:

Kishi, Taro ; Citrome, Leslie ; Sakuma, Kenji...
Psychiatry and Clinical Neurosciences.  78 (2024)  4 - p. 260-262 , 2024
 
?
8

Newer antidepressant for Japanese adults with major depress..:

Kishi, Taro ; Sakuma, Kenji ; Hatano, Masakazu...
Neuropsychopharmacology Reports.  44 (2023)  1 - p. 216-220 , 2023
 
?
9

Serotonin 3 receptor antagonists for obsessive-compulsive d..:

Hamanaka, Shun ; Kishi, Taro ; Sakuma, Kenji...
Journal of Psychiatric Research.  167 (2023)  - p. 132-138 , 2023
 
?
13

Phosphodiesterase type 5 inhibitors for the treatment of se..:

Sakuma, Kenji ; Kishi, Taro ; Sanji, Shohei...
Psychiatry and Clinical Neurosciences.  77 (2023)  5 - p. 297-299 , 2023
 
?
 
?
15

Safety profile of antidepressant for Japanese adults with m..:

Kishi, Taro ; Ikuta, Toshikazu ; Sakuma, Kenji...
Psychiatry and Clinical Neurosciences.  78 (2023)  2 - p. 142-144 , 2023
 
1-15